Description
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
| Cas No. | 878419-78-4 |
|---|---|
| Purity | ≥98% |
| Formula | C14H10F3N5O2 |
| Formula Wt. | 337.26 |
| IUPAC Name | 1,6-Dimethyl-3-[4-(trifluoromethyl)phenyl]pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione |
| Solubility | DMSO: 11.5 mg/mL |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Gotoh Y, Doi A, Furuta E, et al. Novel antibacterial compounds specifically targeting the essential WalR response regulator. J Antibiot (Tokyo). 2010 Mar;63(3):127-34. PMID: 20111065.
Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...
Endogenous tachykinin peptide, involved in infl...
Endogenous RF-amide peptide, involved in nocice...
Analog of glutamate
Endogenous neuropeptide hormone, lowers extrace...
Immunostimulator, adjuvant.
Endogenous neuropeptide, involved in nociceptio...
MDM2 inhibitor.
ACE inhibitor.
Pt-based DNA cross-linker.
Wnt signaling inhibitor.
Imidazole; HMG-CoA reductase, 14-α demethylase...
FLT3, PDGFR, c-Kit inhibitor.
Mycotoxin metabolite
Avermectin; glu-gated Cl- channel activator, Gl...
NO donor; annexin A2 inhibitor.
Cysteine-ITC conjugate, antioxidant.
Endogenous peptide, involved in vasoconstrictio...
AhR agonist.
HEXIM1 activator.